"[]'The FDA has an office for branded drugs. It has an office for generic drugs and for over-the-counter drugs. Why doesn’t the FDA have an office for compounded drugs too? Why don’t they bring compounding out of the shadows?” asks Mark Baum, Imprimis’ CEO."
quoted here
quoted here
No comments:
Post a Comment